PATENT CLAIM ANALYSIS

Application Number: 15760978
Application Type: Utility
Filing Date: 2018-03
Publication Date: 2018-09
Patent Classification: ["514", "252180"]

Abstract:
This disclosure relates to the use of kinase inhibitor to treat or prevent infectious diseases such as tuberculosis. In certain embodiments, this disclosure relates to treating or preventing an infectious disease comprising administering an effective amount of a kinase inhibitor or other compound disclosed herein to a subject in need thereof. In certain embodiments, the disclosure relates to methods of treating or preventing tuberculosis comprising administering a kinase inhibitor to a subject in need thereof. In certain embodiments, the subject is diagnosed with  Mycobacterium tuberculosis  (Mtb) that is resistant to multiple antibiotic agents.

Claim (Index 9):
A pharmaceutical product comprising a combination of imatinib and an antibiotic or antiviral agent.

Metadata:
- Claim Count in Document: 3.0
- Percentile: 90.0
- Lexical Diversity: 1.92453
- Patent Class: 514.0
- Transitional Phrase Type: open
- Component Type: 1
- Foreign Priority: False
- Related Applications: ['12969659', '13265716', '15634593', '14354059', '14832333']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.6180302029801382
- 35 USC 102 Novelty (BERT): 0.4782412229640667
- Combined Prediction Score: 0.6040513049785311
- Mean Citation Score: 122.486757
- Max Citation Score: 124.76732
- Similarity Product: 87.11493587456226

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 0
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test